Restricted Calorie Ketogenic Diet for the Treatment of Glioblastoma Multiforme

@article{Maroon2013RestrictedCK,
  title={Restricted Calorie Ketogenic Diet for the Treatment of Glioblastoma Multiforme},
  author={J. Maroon and J. Bost and Austin Amos and G. Zuccoli},
  journal={Journal of Child Neurology},
  year={2013},
  volume={28},
  pages={1002 - 1008}
}
Glioblastoma multiforme is the most common malignant primary brain tumor in adults and generally considered to be universally fatal. Glioblastoma multiforme accounts for 12% to 15% of all intracranial neoplasms and affects 2 to 3 adults per every 100,000 in the United States annually. In children glioblastoma multiforme accounts for only approximately 7% to 9% of central nervous system tumors. The mean survival rate in adults after diagnosis ranges from 12 to 18 months with standard therapy and… Expand
The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature
TLDR
Recent clinical findings have demonstrated that induced hypoglycemia and ketogenic diet are tolerable and can potentially be an adjuvant to standard treatments, such as surgery and chemoradiation. Expand
Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement
TLDR
Treatment of GBM patients with 4:1 KD using total meal replacement program with standardized recipes was well tolerated and one patient with recurrent GBM and progression on bevacizumab experienced a remarkable symptom reversal, tumor shrinkage, and edema resolution. Expand
Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma
TLDR
Studies in preclinical models show that calorie restricted ketogenic diets (KD-R), anti-glycolytic drugs, and hyperbaric oxygen therapy can reduce availability of glucose and glutamine in the tumor microenvironment while enhancing oxidative stress in tumor cells. Expand
MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet.
TLDR
A huge increase in beta-hydroxybutyrate was detected in tumor tissue as compared to normal brain, which may suggest either elevated uptake/release of bHB by tumor cells, or the inability of tumor cells in this context to use it for mitochondrial metabolism. Expand
Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults. The standard therapy for GBM is maximal surgical resection followed by radiotherapy with concurrent and adjuvantExpand
Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
TLDR
The long-term survival of this patient, now at 80 months, could be due in part to a therapeutic metabolic synergy between KMT and the IDH1 mutation that simultaneously target the glycolysis and glutaminolysis pathways that are essential for GBM growth. Expand
Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature
TLDR
KD is safe and without major side effects; ketosis can be induced using customary foods; treatment with KD may be effective in controlling the progression of some gliomas; and further studies are needed to determine factors that influence the effectiveness of KD. Expand
Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies.
TLDR
Preclinically, KCRDs reduced tumor growth, but only a small majority of the in vivo studies found improved survival, and these effects were stronger in groups with decreased blood glucose than in those with increased ketones, and also when other therapies were used concomitantly. Expand
Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma
TLDR
It is suggested that many cells appearing as TAM within GBM could be neoplastic with properties of macrophages/ microglia, and the genomic abnormalities seen in cancer cells arise as downstream secondary effects of disturbed energy metabolism and are unlikely to provide useful information for therapeutic treatment strategies for the majority of GBM patients. Expand
Role of ketogenic metabolic therapy in malignant glioma: A systematic review.
TLDR
Emerging clinical data will help answer questions concerning safety and efficacy of KMT, and are aiming to identify the most promising KMT regimen, compatibility with other anti-cancer treatments, ethical aspects, and impact on quality of life of cancer patients. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
The Restricted Ketogenic Diet : An Alternative Treatment Strategy for Glioblastoma Multiforme a report
Glioblastoma Multiforme (GBM) Glioblastoma multiforme (GBM) is considered the most malignant of primary brain cancers with only about 12% of patients living beyond 36 months (long-term survivors).1,2Expand
Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report
TLDR
This is the first report of confirmed GBM treated with standard therapy together with a restricted ketogenic diet, and as rapid regression of GBM is rare in older patients following incomplete surgical resection and standard therapy alone, the response observed in this case could result in part from the action of the calorie restrictedketogenic diet. Expand
Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.
TLDR
While this ketogenic diet does not replace conventional antineoplastic treatments, these preliminary results suggest a potential for clinical application which merits further research. Expand
Canadian recommendations for the treatment of glioblastoma multiforme
Recommendation 1 Management of patients with glioblastoma multiforme (gbm) should be highly individualized and should take a multidisciplinary approach involving neuro-oncology, neurosurgery,Expand
Ketogenic Diet for the Treatment of Refractory Epilepsy in Children: A Systematic Review of Efficacy
TLDR
Although controlled trials are lacking, the evidence is sufficient to determine that the ketogenic diet is efficacious in reducing seizure frequency in children with refractory epilepsy. Expand
Metabolic management of brain cancer.
TLDR
This work proposes an alternative approach to brain cancer management that exploits the metabolic flexibility of normal cells at the expense of the genetically defective and metabolically challenged tumor cells. Expand
Targeting energy metabolism in brain cancer: review and hypothesis
TLDR
A radically different approach to brain cancer management is proposed that combines metabolic control analysis with the evolutionarily conserved capacity of normal cells to survive extreme shifts in physiological environment. Expand
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet
TLDR
The results suggest that management of malignant astrocytoma with restricted ketogenic diets could be enhanced when combined with drugs that inhibit glycolysis. Expand
Genetic alterations and signaling pathways in the evolution of gliomas
TLDR
The current status of genetic alterations and signaling pathways operative in the evolution of astrocytic and oligodendroglial tumors is summarized. Expand
Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial
TLDR
Pilot data suggest that a ketogenic diet is suitable for even advanced cancer patients and has no severe side effects and might improve aspects of quality of life and blood parameters in some patients with advanced metastatic tumors. Expand
...
1
2
3
4
5
...